# A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain

> **NCT05445167** · PHASE3 · COMPLETED · sponsor: **Kissei Pharmaceutical Co., Ltd.** · enrollment: 89 (actual)

## Conditions studied

- Uterine Fibroids (MeSH Heading: Leiomyoma)

## Interventions

- **DRUG:** KLH-2109
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05445167
- **Lead sponsor:** Kissei Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-11
- **Primary completion:** 2024-02-16
- **Final completion:** 2024-02-16
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05445167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05445167, "A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05445167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*